Interventional Pain Procedures, Neuromodulation, and COVID-19

[Recorded May 7, 2020]

Preparing Your Re-entry Plan

Mapping the Future of Pain Procedures with Neuromodulation and COVID-19

Eric J. Grigsby, MD, MBA and NANS Board Member, Stephanie G. Vanterpool, MD, MBA review exploring NANS’ Neuromodulation Device Algorithm for COVID-19.

Learn:

• How to classify the management of currently implanted neuromodulation devices as “elective” or “essential”
• Considerations for pump management during the pandemic
• Stages for re-entry: testing, tracing, and community health
• How to get back to a “new normal” once we resume doing procedures…. i.e. It won’t be business as usual

This guidance refers to the management of currently implanted neuromodulation devices. With rare exception, implantation of new devices is considered elective in the current COVID-19 environment.

This nonaccredited educational webinar is provided for information only.